📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lophius Biosciences

1.1 - Company Overview

Lophius Biosciences Logo

Lophius Biosciences

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative products for the diagnosis of acute infectious and autoimmune diseases, plus custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lophius Biosciences

Apitope Logo

Apitope

HQ: United Kingdom Website
  • Description: Provider of discovery and development of disease-modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis; first product candidate licensed to Merck Serono.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apitope company profile →
Natrogen Therapeutics Logo

Natrogen Therapeutics

HQ: United States Website
  • Description: Provider of Natura-alpha, a small-molecule oral compound undergoing clinical trials for patients with ulcerative colitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Natrogen Therapeutics company profile →
Dianthus Therapeutics Logo

Dianthus Therapeutics

HQ: United States Website
  • Description: Provider of targeted therapeutics for serious autoimmune diseases, including DNTH103, a long-acting monoclonal antibody that selectively inhibits active C1s in the classical complement pathway. DNTH103 is in Phase 2 for generalized myasthenia gravis, with plans for multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy, using YTE half-life extension for less frequent dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dianthus Therapeutics company profile →
Step Pharma Logo

Step Pharma

HQ: France Website
  • Description: Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Step Pharma company profile →
Sionna Therapeutics Logo

Sionna Therapeutics

HQ: United States Website
  • Description: Provider of small molecule therapies for cystic fibrosis, including SION-638, an NBD1 stabilizer in Phase 1 clinical trials designed to restore CFTR function; SION-109, a small molecule targeting the ICL4–NBD1 interface, in Phase 1; and SION-719, a second series NBD1 stabilizer in preclinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sionna Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lophius Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lophius Biosciences

2.2 - Growth funds investing in similar companies to Lophius Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lophius Biosciences

4.2 - Public trading comparable groups for Lophius Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lophius Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lophius Biosciences

What does Lophius Biosciences do?

Lophius Biosciences is a provider of innovative products for the diagnosis of acute infectious and autoimmune diseases, plus custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

Who are Lophius Biosciences's competitors?

Lophius Biosciences's competitors and similar companies include Apitope, Natrogen Therapeutics, Dianthus Therapeutics, Step Pharma, and Sionna Therapeutics.

Where is Lophius Biosciences headquartered?

Lophius Biosciences is headquartered in Germany.

How many employees does Lophius Biosciences have?

Lophius Biosciences has 1,000 employees 🔒.

When was Lophius Biosciences founded?

Lophius Biosciences was founded in 2010 🔒.

What sector and industry vertical is Lophius Biosciences in?

Lophius Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lophius Biosciences

Who are the top strategic acquirers in Lophius Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Lophius Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lophius Biosciences?

Top strategic M&A buyers groups and sectors for Lophius Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lophius Biosciences's sector and industry vertical

Which are the top PE firms investing in Lophius Biosciences's sector and industry vertical?

Top PE firms investing in Lophius Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lophius Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lophius Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lophius Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lophius Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lophius Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lophius Biosciences?

The key public trading comparables and valuation benchmarks for Lophius Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lophius Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lophius Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lophius Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lophius Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lophius Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Lophius Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lophius Biosciences